久精品免费观看国产33,精品国产电影在线看免,在线观看aⅴ免费,久久99久久久一本精品

        • 您當(dāng)前所在位置:首頁(yè) > 資訊信息 > 新品上市
          ?PEG-DSPE穩(wěn)定pH敏感脂質(zhì)體的血液清除作用
          發(fā)布時(shí)間:2025-07-11     作者:zyl   分享到:

          文獻(xiàn):Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells

          作者:T Ishida a 1, M.J Kirchmeier a 2, E.H Moase a, S Zalipsky b, T.M Allen 

          文獻(xiàn)鏈接:

          https://www.sciencedirect.com/science/article/pii/S0005273601004096

          摘要:

          radiolabeled [125I]TI were prepared and injected into the tail vein of mice at a PL dose of 0.5 μmol/mouse. Circulation times increased with increasing concentration of mPEG-DSPE in either DOPE or DOPE/CHEMS liposome formulations (Fig. 6A,B). Approximately 5–10% of the injected liposomes still remained in the blood 24 h after injection of liposomes containing 10 mol% mPEG-DSPE. Injection of DOPE or DOPE/CHEMS liposomes that were not stabilized with mPEG-DSPE resulted in rapid clearance of the liposomes. Liposomes accumulated primarily in the liver and spleen (not shown). Inclusion of from 2 to 9 mol% of mPEG-S-S-DSPE did not increase the circulation times for either the DOPE (Fig. 6C) or DOPE/CHEMS (Fig. 6D) formulations. All mPEG-S-S-DSPE formulations contained 1 mol% mPEG-DSPE to mimic the effect of adding 1 mol% coupling lipid to the formulations in targeting experiments. Increasing amounts of mPEG-S-S-DSPE in the formulations did not increase circulation half-lives of the formulations to any significant extent (Fig. 6A,B), likely because the mPEG-S-S-DSPE was rapidly cleaved in plasma.

          ?

          Gso6k8KkkM7RycDaQNRv.png

          為了確定脂質(zhì)體制劑的藥代動(dòng)力學(xué),制備了含有放射性標(biāo)記的[125I]TI的脂質(zhì)體,并以0.5μmol/小鼠的PL劑量注射到小鼠的尾靜脈中。循環(huán)時(shí)間隨著DOPE或DOPE/CHEMS脂質(zhì)體制劑中mPEG-DSPE濃度的增加而增加。

          注射含有10mol%mPEG-DSPE的脂質(zhì)體24小時(shí)后,約5-10%的注射脂質(zhì)體仍留在血液中。注射未經(jīng)mPEG-DSPE穩(wěn)定的DOPE或DOPE/CHEMS脂質(zhì)體可快速清除脂質(zhì)體。脂質(zhì)體主要積聚在肝臟和脾臟中。

          加入2至9mol%的mPEG-S-S-DSPE不會(huì)增加DOPE或DOPE/CHEMS制劑的循環(huán)時(shí)間。所有mPEG-S-S-DSPE制劑均含有1 mol%mPEG-DSPE,以模擬在靶向?qū)嶒?yàn)中向制劑中添加1 mol%偶聯(lián)脂質(zhì)的效果。制劑中mPEG-S-S-DSPE含量的增加并沒有顯著延長(zhǎng)制劑的循環(huán)半衰期,這可能是因?yàn)閙PEG-S-S-D SPE在血漿中迅速裂解。

          相關(guān)推薦:

          RB-PEG-DSPE

          STA-PEG-CHO

          STA-PEG-COOH

          STA-PEG-FA

          STA-PEG-FITC

          STA-PEG-Mal

          STA-PEG-NBD

          STA-PEG-NH2

          STA-PEG-OH

          STA-PEG-SC

          STA-PEG-SH

          以上文章內(nèi)容來(lái)源各類期刊或文獻(xiàn),如有侵權(quán)請(qǐng)聯(lián)系我們刪除!

          庫(kù)存查詢